Earlier this month, Dr. Carl Alving, MHRP’s Chief of Adjuvant and Antigen Research, was inducted as a 2016 Fellow of the National Academy of Inventors (NAI) in a ceremony at the Kennedy Library and Museum in Boston.
NAI elects as Fellows academic inventors who have “demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society."
Dr. Alving has been with the Walter Reed Institute of Research since 1970. He has been an author or coauthor on approximately 300 scientific publications (more than 250 peer-reviewed papers) in the fields of adjuvants, antigens, antibodies, complement, lipid biochemistry and immunology and liposomes as drug carriers and carriers of vaccines. He has created adjuvants for many types of experimental vaccines, including vaccines to malaria, HIV, meningococcal infection, heroin addiction, biological threat agents and prostate and intestinal cancer. He holds 31 U.S. patents.
"The research and scientific environment at the Walter Reed Army Institute of Research that fostered an environment of creativity and innovation led to this national recognition,” said Dr. Alving. “Technology transfer activities that resulted from these activities have supported and benefited many military missions.”
With the election of the 2016 class, there are now 757 NAI Fellows, representing 229 research universities and governmental and non-profit research institutes. The 2016 Fellows are named inventors on 5,437 issued U.S. patents, bringing the collective patents held by all NAI Fellows to more than 26,000 patents.